Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.38

-9.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (1606)	9/12/2000 3:06:44 PM
From: Biomaven	Read Replies (1) of 52153

ij, Here's a link to a cost comparison on their site: cdic.com Looks like a disposables cost of $10 per procedure, and an amortization cost of $31 per procedure based on 15 patients per month over 5 years. Margins for the last quarter were 66%. Not sure of the relative breakdown between disposables and equipment. Sales last quarter benefited from some pent-up demand and from sales of training systems to GE Marquette. Market doesn't seem to care for small cap device companies right now. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next